Overview

Memantine for Enhanced Stroke Recovery

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This will be a randomized double blind placebo-controlled pilot study using a repeated measures design in which participants with acute ischemic stroke and upper extremity weakness are randomized to either drug or placebo

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Utah

Treatments:

Memantine